Chinese Operative Steals American Intel

Chinese Operative Steals American Intel

( – Trade secrets are protected intellectual property. Sharing them with anybody is a crime — especially when it includes giving highly valuable information to a country that isn’t a US ally.

On January 3, Lucy Xi, a former scientist at GlaxoSmithKline (GSK), pleaded guilty to sharing trade secrets with a Chinese pharmaceutical company. Three other defendants were also in on the fraud to steal valuable information about the use of monoclonal antibodies.

Xi and her cohorts created the company Renopharma, which the Chinese government funded. They used Renopharma to get into GSK and steal the trade secrets. The intention was to provide this information to the Chinese government and allow pharmaceutical companies in that country to secure patents.

The research Xi shared relates to the current COVID-19 pandemic because monoclonal antibodies are an effective treatment against the virus. While the theft occurred in 2015, well before the pandemic, there has been an ongoing concern about China stealing trade secrets from the United States. The actions of XI and her colleagues broke intellectual property laws and threatened innovation, which is the backbone of the US economy.

Xi will return to court for sentencing on April 12. She didn’t comment on the plea or pending sentencing.

Copyright 2022,

Jane Sawyer is a dedicated researcher and writer for Informing News with a specialty in engaging news seeking audiences. Focus on quick and well researched factual information is Jane Sawyer's single most important value.